Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Virus susceptibility gene finally cloned

Sep. 6, 1996

Thalidomide effective in chronic erythema multiforme

Sep. 6, 1996

Bayer discloses antibacterial agents

Sep. 6, 1996

New antibiotics from Zeneca

Sep. 6, 1996

Carbapenems reported by Merck & Co.

Sep. 6, 1996

Merck & Co. describes antibiotics active against resistant staphylococci

Sep. 6, 1996

Japanese companies report cephems

Sep. 6, 1996

NSC-665158: HIV-1 reverse transcriptase inhibitor analogue

Aug. 30, 1996

Antiherpes compounds from Bio-Mega/Boehringer Ingelheim

Aug. 30, 1996

Influenza A virus sialidase inhibitors from Glaxo Wellcome

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...